Conrad Ziembinski DO

Rheumatology•Coral Springs, FL

Lupus & Related, Osteoporosis & Bone Metabolism, Rheumatoid Arthritis & Related

Physician

Join to View Full Profile

9750 NW 33rd StSuite 116Coral Springs, FL 33065
Phone+1 954-341-5034
Fax+1 954-341-9190

Summary

Dr. Conrad Ziembinski is a rheumatologist in Coral Springs, FL and Miami Beach, FL and is affiliated with multiple hospitals in the area, including Broward Health Coral Springs and Mount Sinai Medical Center. He received his medical degree from A.T. Still University, School of Osteopathic Medicine in Arizona and has been in practice 6 years. He also speaks multiple languages, including Polish and Spanish. He specializes in lupus & related, osteoporosis & bone metabolism, and rheumatoid arthritis & related. He has 2 publications and 10 citings.

Education & Training

A.T. Still University, School of Osteopathic Medicine in ArizonaClass of 2016

Certifications & Licensure

FL State License 2018 - 2026
AOA Board of Internal Medicine Internal Medicine
AOA Board of Internal Medicine Rheumatology

Clinical Trials

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis Start of enrollment: 2022 Mar 03
Completed
Rheumatology Biorepository Start of enrollment: 2021 Mar 10
ENROLLING_BY_INVITATION
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US Start of enrollment: 2022 Mar 25
Recruiting
Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants Start of enrollment: 2022 May 12
Completed
Phase 1
RA-PRO PRAGMATIC TRIAL Start of enrollment: 2021 Sep 22
RECRUITING
PHASE3
Roles: Contact
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus Start of enrollment: 2020 Aug 12
COMPLETED
PHASE3
COVID-19 Impact on Rheumatic Patients Start of enrollment: 2020 Apr 20
Completed
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus Start of enrollment: 2021 May 25
RECRUITING
PHASE3
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA Start of enrollment: 2022 Mar 02
TERMINATED
PHASE3
COVID-19 VaccinE Response in Rheumatology Patients Start of enrollment: 2021 Nov 15
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

3 citations
Efficacy and Safety of Anti-Interleukin-17A Monoclonal Antibody Secukinumab in Treatment of Ankylosing Spondylitis: A Meta-Analysis.
Gennadiy A. Katsevman, Gonzalo Mariscal, Carlos Barrios, Pedro Domenech-Fernandez, Conrad Ziembinski
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2020-10-21
8 citations
Hashimoto Encephalopathy as a Complication of Autoimmune Thyroiditis.
Alixandria A Fiore, Wilson B. Pfeiffer, Syed A. A. Rizvi, Anais Cortes, Conrad Ziembinski
Medical Principles and Practice. 2019-01-01

Other Languages

Polish, Spanish